Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Meridian Bioscience, Inc. VIVO
$33.97
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
1488830434.00000000
-
week52high
34.38
-
week52low
23.44
-
Revenue
333018000
-
P/E TTM
-552
-
Beta
0.00000000
-
EPS
1.61100000
-
Last Dividend
9.88208600
-
Next Earnings Date
04 мая 2023 г. в 12:30
Описание компании
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
HC Wainwright & Co. | Neutral | Buy | 08 июл 2022 г. |
HC Wainwright & Co. | Buy | Buy | 07 февр 2022 г. |
HC Wainwright & Co. | Buy | Buy | 15 ноя 2021 г. |
HC Wainwright & Co. | Buy | Buy | 09 авг 2021 г. |
HC Wainwright & Co. | Buy | Buy | 10 мая 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Sazdanoff Catherine | D | 0 | 5656 | 31 янв 2023 г. |
Sazdanoff Catherine | D | 0 | 5656 | 31 янв 2023 г. |
Williams Felicia | D | 0 | 5656 | 31 янв 2023 г. |
Williams Felicia | D | 0 | 5656 | 31 янв 2023 г. |
McIlwraith John | D | 0 | 5656 | 31 янв 2023 г. |
McIlwraith John | D | 0 | 5656 | 31 янв 2023 г. |
Rice John McCune Jr. | D | 0 | 5656 | 31 янв 2023 г. |
Rice John McCune Jr. | D | 0 | 5656 | 31 янв 2023 г. |
Bihl Anthony P III | D | 0 | 5656 | 31 янв 2023 г. |
Bihl Anthony P III | D | 0 | 5656 | 31 янв 2023 г. |
Новостная лента
Medical Devices Stock Pumps Up Buy Point With New Innovations
Investors Business Daily
17 ноя 2022 г. в 17:15
After launching three new products and posting a second quarter of rising EPS growth, medical devices leader Merit Medical Systems is probing a new buy point. The post Medical Devices Stock Pumps Up Buy Point With New Innovations appeared first on Investor's Business Daily.
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
The Motley Fool
07 окт 2022 г. в 06:25
This quartet of stocks has plenty of growth ahead and is already profitable.